Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CXS | Ann: Notice of Compulsory Acquisition | 06:52 | 1 | 808 | |||
|
|||||||
CXS | Ann: Removal from Official List close of trading | 22/07/11 | 0 | 519 | |||
|
|||||||
CXS | Ann: Change in substantial holding | 21/07/11 | 0 | 561 | |||
|
|||||||
CXS | diagnostic tests used with targeted drug thera | 13/07/11 | 0 | 427 | |||
|
|||||||
CXS | Ann: Change in substantial holding | 12/07/11 | 0 | 568 | |||
|
|||||||
CXS | Ann: Board Changes and Director's Interest No | 01/07/11 | 0 | 475 | |||
|
|||||||
CXS | Ann: Suspension at close of trading 21/6/11 | 21/06/11 | 0 | 489 | |||
|
|||||||
CXS | Ann: Notice of compulsory acquisition following T | 16/06/11 | 0 | 320 | |||
|
See All Discussions